Health

Indore (Madhya Pradesh) [India], May 19: Children diagnosed with autism spectrum disorder, ADHD, intellectual disability, cerebral palsy, Down syndrome, and other neurodevelopmental conditions are competing at national levels, winning inter-school tournaments, and building independent lives — when supported through structured, individualized intervention from early childhood. Urjasvini Child Development Centre, a leading child psychology and special needs institution in Indore, Madhya Pradesh, has now supported over 5,000 children and families across India, and the outcomes are quietly rewriting what families once believed was possible. Dr. Vini Jhariya, Clinical and Child Psychologist, TEDx Speaker, and Founder of Urjasvini Child Development Centre and Urjasvini Special School, Indore, has spent over a…

From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage Geneva [Switzerland], May 16: In a proud moment for India, Naman Gosalia’s consistent advocacy for making cardiovascular prevention the default, not optional, is now bringing India-born AnginaX into global healthcare and public-health conversations alongside presidents of leading cardiology societies, global healthcare leaders, policymakers, institutions, and international public-health stakeholders from across the world. His growing voice on prevention-first healthcare has led to invitations to discussions at World Heart Federation forums and broader health-policy conversations aligned with the United Nations ecosystem, where the future of…

New Delhi [India], May 14: Paras Health has announced the launch of Umeed Ke Sitare, a dedicated initiative aimed at celebrating cancer survivors and promoting conversations around life beyond cancer, emotional healing, and holistic oncology care. The initiative will be showcased on May 16 in New Delhi, where cancer survivors, caregivers, and leading oncologists from across the Paras Health network will come together on one platform to honour stories of courage, resilience, and recovery. In a key highlight of the presentation, oncology specialists from Paras Health hospitals across different states and regions will walk alongside cancer survivors — symbolising the…

Jodhpur (Rajasthan) [India], May 12: In a step that brings traditional Ayurveda closer to modern clinical validation, Krishna’s Herbal & Ayurveda has announced the successful completion of a clinical study on its She Care Juice, designed to support women dealing with PCOD-related concerns. For millions of women, PCOD is not just a medical term. It often shows up as irregular periods, acne, unwanted facial hair, weight gain, emotional stress, and a constant feeling that the body is out of balance. With She Care Juice, Krishna’s Ayurveda has focused on a formulation that supports women’s health naturally, while now also being backed…

New Delhi [India], May 11: Every week in India, heart disease claims more than 59,000 lives. That is 350 people every hour dying in the country, accounting for 32% of all fatalities in 2023 alone, according to the Global Burden of Disease study. These are not numbers that should surprise us anymore. And yet, the stories behind them still do. A founder in his late 40s. A CFO who just passed his annual check-up. A senior executive whose cholesterol was “well within range.” We keep describing these events as sudden. They are not. What they are, almost without exception, is…

Retinoblastoma in Children: Why Early Detection Matters More Than Most Parents Realise New Delhi [India], April 30: Most parents never expect a family photo to raise a medical concern. But for some parents, that is exactly what happens. The camera flash catches something different, one eye glows red as it should, and the other shows a strange white or pale reflection. Easy to dismiss as a glitch. Easy to scroll past. For many children, that white glow in the eye is the first visible sign that something is wrong inside the eye. Retinoblastoma is not a condition most people grow…

Retinoblastoma in Children: Why Early Detection Matters More Than Most Parents Realise New Delhi [India], April 30: Most parents never expect a family photo to raise a medical concern. But for some parents, that is exactly what happens. The camera flash catches something different, one eye glows red as it should, and the other shows a strange white or pale reflection. Easy to dismiss as a glitch. Easy to scroll past. For many children, that white glow in the eye is the first visible sign that something is wrong inside the eye. Retinoblastoma is not a condition most people grow…

New Delhi [India], April 27: The preventive healthcare segment in India is witnessing steady growth, and global nutraceutical brands are increasingly looking at the country as a key market. Tapping into this momentum, Nature’s Way Alive, a widely recognised US-based nutraceutical brand, has officially entered the Indian market. The brand is being introduced in India by Dr. Willmar Schwabe India Pvt. Ltd., a part of the globally established Schwabe Group. With a strong legacy in herbal and natural medicine, the group aims to strengthen its presence in the country’s expanding wellness and dietary supplement category through this launch. The Schwabe Group…

New Delhi [India], April 25: A bare or patchy scalp not only impacts one’s look but also self-esteem and personality. Due to the long-term impact of baldness on personal and professional life, the demand for permanent hair restoration has reached an all-time high. Over the years, New Delhi has cemented its position as a hair restoration hub with people from across the country and abroad coming here for hair transplant procedures. However, with a surge in providers, patients often find themselves overwhelmed by choices. While the market is saturated with options, the difference between a life-changing transformation and a medical complication lies…

London [United Kingdom], April 25: At the Charing Cross Symposium 2026 this week, one theme kept resurfacing in quiet conversations between clinicians: what happens after the first year? It’s a question that doesn’t always make headlines, but it tends to shape real-world decisions. The preliminary three-year data from the SIRONA randomised trial, presented by Prof. Ulf Teichgräber, leaned directly into that gap. The study, backed by Concept Medical Inc., compares sirolimus-coated and paclitaxel-coated balloon angioplasty in femoropopliteal artery disease — an area where treatment choices have long been influenced by familiarity as much as by evidence. Looking Past the First…